BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24725154)

  • 1. Therapeutic efficacy of the combination of doxorubicin-loaded liposomes with inertial cavitation generated by confocal ultrasound in AT2 Dunning rat tumour model.
    Mestas JL; Fowler RA; Evjen TJ; Somaglino L; Moussatov A; Ngo J; Chesnais S; Røgnvaldsson S; Fossheim SL; Nilssen EA; Lafon C
    J Drug Target; 2014 Sep; 22(8):688-97. PubMed ID: 24725154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility study of cavitation-induced liposomal doxorubicin release in an AT2 Dunning rat tumor model.
    Lafon C; Somaglino L; Bouchoux G; Mari JM; Chesnais S; Ngo J; Mestas JL; Fossheim SL; Nilssen EA; Chapelon JY
    J Drug Target; 2012 Sep; 20(8):691-702. PubMed ID: 22845841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cavitation-induced release of liposomal chemotherapy in orthotopic murine pancreatic cancer models: A feasibility study.
    Camus M; Vienne A; Mestas JL; Pratico C; Nicco C; Chereau C; Marie JM; Moussatov A; Renault G; Batteux F; Lafon C; Prat F
    Clin Res Hepatol Gastroenterol; 2019 Nov; 43(6):669-681. PubMed ID: 31031131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonosensitive dioleoylphosphatidylethanolamine-containing liposomes with prolonged blood circulation time of doxorubicin.
    Evjen TJ; Hagtvet E; Nilssen EA; Brandl M; Fossheim SL
    Eur J Pharm Sci; 2011 Jul; 43(4):318-24. PubMed ID: 21620968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy.
    Thomas E; Menon JU; Owen J; Skaripa-Koukelli I; Wallington S; Gray M; Mannaris C; Kersemans V; Allen D; Kinchesh P; Smart S; Carlisle R; Vallis KA
    Theranostics; 2019; 9(19):5595-5609. PubMed ID: 31534505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: evaluation of drug distribution in a rat glioma model.
    Aoki H; Kakinuma K; Morita K; Kato M; Uzuka T; Igor G; Takahashi H; Tanaka R
    Int J Hyperthermia; 2004 Sep; 20(6):595-605. PubMed ID: 15370816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model.
    Sun T; Zhang Y; Power C; Alexander PM; Sutton JT; Aryal M; Vykhodtseva N; Miller EL; McDannold NJ
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10281-E10290. PubMed ID: 29133392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in vitro and in vivo.
    Zhao YZ; Dai DD; Lu CT; Lv HF; Zhang Y; Li X; Li WF; Wu Y; Jiang L; Li XK; Huang PT; Chen LJ; Lin M
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1090-8. PubMed ID: 22188116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced drug delivery in rabbit VX2 tumours using thermosensitive liposomes and MRI-controlled focused ultrasound hyperthermia.
    Staruch RM; Ganguly M; Tannock IF; Hynynen K; Chopra R
    Int J Hyperthermia; 2012; 28(8):776-87. PubMed ID: 23153219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination.
    Fonseca NA; Gomes-da-Silva LC; Moura V; Simões S; Moreira JN
    J Control Release; 2014 Dec; 196():122-31. PubMed ID: 25305563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
    Ishida T; Atobe K; Wang X; Kiwada H
    J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
    J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.
    Loi M; Marchiò S; Becherini P; Di Paolo D; Soster M; Curnis F; Brignole C; Pagnan G; Perri P; Caffa I; Longhi R; Nico B; Bussolino F; Gambini C; Ribatti D; Cilli M; Arap W; Pasqualini R; Allen TM; Corti A; Ponzoni M; Pastorino F
    J Control Release; 2010 Jul; 145(1):66-73. PubMed ID: 20346382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonosensitive theranostic liposomes for preclinical in vivo MRI-guided visualization of doxorubicin release stimulated by pulsed low intensity non-focused ultrasound.
    Rizzitelli S; Giustetto P; Cutrin JC; Delli Castelli D; Boffa C; Ruzza M; Menchise V; Molinari F; Aime S; Terreno E
    J Control Release; 2015 Mar; 202():21-30. PubMed ID: 25626083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple injections of pegylated liposomal Doxorubicin: pharmacokinetics and therapeutic activity.
    Charrois GJ; Allen TM
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1058-67. PubMed ID: 12808004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice.
    Hagtvet E; Evjen TJ; Olsen DR; Fossheim SL; Nilssen EA
    J Drug Target; 2011 Sep; 19(8):701-8. PubMed ID: 21524240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl).
    Working PK; Dayan AD
    Hum Exp Toxicol; 1996 Sep; 15(9):751-85. PubMed ID: 8880211
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.